TOTAL VOLUME:

$166.8b

24H VOL:

$89,987,006

24H TRANSACTIONS:

3,258,908,236

OPEN INTEREST:

$1,696,807,265

332,071

Markets across

35,607

events

MATCHED EVENTS:

3,434

PLATFORM COVERAGE:

5

Polymarket:

36%

VS.

Kalshi:

64%

BETA
Dashboards
Tour
All
New Coronavirus Pandemic in 2026?
Health
polymarket

New Coronavirus Pandemic in 2026?

Jan 6, 2026, 2:41 PM ET - Dec 31, 2026, 11:59 PM ET
Total volume:
$33,048
Volume 24h:
--
100%
Liquidity:
$7,195
2%
Open interest:
$10,914--

New Coronavirus Pandemic in 2026?

 - Polymarket

New Coronavirus Pandemic in 2026? - Polymarket

1W

News

Positive

Negative

Neutral

Hover marker for details

Vol.

·

Resolves Dec 31, 2026

New Coronavirus Pandemic in 2026?

2%chance
Amount

$

Trade on
polymarket

Trade on Polymarket

At 1.7¢ buys you 5,882 shares | Odds: 2% Total Payout: $5,882 | Net Profit: $5,782 Multiplier: 58.82x | ROI: 5,782% APY not meaningful 39 days to resolution
You will be redirected to the platform to complete this trade.
Outcome
Trade
Chance %
Price
Spread
Liquidity
Volume
24h Vol Δ
7d Vol Δ
Open Interest
Ends in
Result
polymarket

New Coronavirus Pandemic in 2026?

Trade
2%
Yes 1.7¢No 98.6¢
0.3¢
$7,195
$33,048
0%
2%
--
1mo 1w 2d
Active
Total markets: 1

Intro

This market tracks whether the World Health Organization will declare a new coronavirus pandemic distinct from COVID-19 during 2026. On Polymarket, the probability of a new coronavirus pandemic occurring stands at 6.0%. Resolution will be determined by official WHO announcements declaring a novel coronavirus pandemic between market creation and December 31, 2026, 11:59 PM ET. Watch for any WHO emergency declarations or pandemic announcements through the end of 2026 to signal a potential resolution to Yes.

Polymarket

This market will resolve to "Yes" if the World Health Organization (WHO) declares a new COVID pandemic other than COVID-19 (SARS-CoV-2) between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source will be official announcements from the World Health Organization.

Frequently asked questions

Currently, the prevailing sentiment in this market suggests a relatively low probability of a new coronavirus pandemic in 2026. This contrasts with some analyst forecasts, which vary widely depending on the models and assumptions used. While some experts predict a heightened risk of future pandemics due to factors like climate change and increased global travel, others believe that advancements in public health infrastructure and vaccine development will mitigate the threat. It’s important to note that prediction markets reflect a real-money consensus, potentially offering a different perspective than traditional expert opinions.

On Polymarket, this market is priced through a continuous auction mechanism where traders buy and sell shares representing their belief in the outcome. The price of a share directly reflects the probability of a new coronavirus pandemic occurring in 2026, as perceived by the market participants. On Polymarket, prices reflect that venue's order book, liquidity, and how traders price the outcome right now. As traders exchange shares, the price adjusts to reflect the latest information and collective intelligence. The current implied probability, as reflected by the share price, is 1.6%.

This market resolves around Jan 1, 2027, with the outcome determined by whether a new coronavirus, distinct from existing variants, causes a pandemic as defined by the World Health Organization (WHO) in the year 2026. The outcome will be verified against credible public reporting from organizations like the WHO and leading public health agencies. Resolution will depend on a clear declaration of a pandemic by these sources, confirming the emergence and widespread transmission of a novel coronavirus strain.

Several signals or events could significantly impact this market. The emergence of a new coronavirus variant with increased transmissibility or virulence would likely drive up the probability of a pandemic. Conversely, significant breakthroughs in antiviral treatments or vaccine technology could lower the perceived risk. Global health security initiatives, such as increased surveillance and pandemic preparedness funding, could also influence market sentiment. Major geopolitical events or widespread outbreaks of other infectious diseases could also indirectly affect the market, shifting focus and resources.